NEUROPACE
Updates & Highlights
NeuroPace, Inc. Files Form 8-K Reporting 2026 Annual Meeting Results and Company Information
NeuroPace, Inc. Files Form 8-K Reporting 2026 Annual Meeting Results and Company Information
Minichart · about 20 hours ago
NeuroPace shareholders elect directors and ratify auditor at annual meeting
NeuroPace shareholders elect directors and ratify auditor at annual meeting
Investing.com · 1 day ago
NeuroPace (NASDAQ: NPCE) investors back board slate and PwC at 2026 meeting
NeuroPace (NASDAQ: NPCE) investors back board slate and PwC at 2026 meeting
Stock Titan · 1 day ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at NeuroPace?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentNeuroPace, Inc. Files Form 8-K Reporting 2026 Annual Meeting Results and Company Information
NeuroPace, Inc. Files Form 8-K Reporting 2026 Annual Meeting Results and Company Information
Minichart · about 20 hours ago
NeuroPace shareholders elect directors and ratify auditor at annual meeting
NeuroPace shareholders elect directors and ratify auditor at annual meeting
Investing.com · 1 day ago
NeuroPace (NASDAQ: NPCE) investors back board slate and PwC at 2026 meeting
NeuroPace (NASDAQ: NPCE) investors back board slate and PwC at 2026 meeting
Stock Titan · 1 day ago
NeuroPace (NPCE) director receives new stock grant and options
NeuroPace (NPCE) director receives new stock grant and options
Stock Titan · 5 days ago
NeuroPace (NPCE) director Fischer receives stock and option awards
NeuroPace (NPCE) director Fischer receives stock and option awards
Stock Titan · 5 days ago
NeuroPace (NPCE) director Uri Geiger receives new share and option grants
NeuroPace (NPCE) director Uri Geiger receives new share and option grants
Stock Titan · 5 days ago
NeuroPace (NPCE) director receives stock grant and 5,368-share option award
NeuroPace (NPCE) director receives stock grant and 5,368-share option award
Stock Titan · 5 days ago
NeuroPace (NPCE) director receives new stock and option grants as compensation
NeuroPace (NPCE) director receives new stock and option grants as compensation
Stock Titan · 5 days ago
NeuroPace (NASDAQ: NPCE) director receives new stock and option grants
NeuroPace (NASDAQ: NPCE) director receives new stock and option grants
Stock Titan · 5 days ago
NPCE Explains How NeuroPace's RNS System Makes Money
NPCE Explains How NeuroPace's RNS System Makes Money
MSN · 6 days ago
NeuroPace (NPCE) CEO Becker has RSU tax withholding of 1,255 shares
NeuroPace (NPCE) CEO Becker has RSU tax withholding of 1,255 shares
Stock Titan · 6 days ago
How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target
How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target
Yahoo Finance · 8 days ago
NeuroPace Wins FDA Nod for ECoG Assistant for Epilepsy Care
NeuroPace Wins FDA Nod for ECoG Assistant for Epilepsy Care
Medical Product Outsourcing · 9 days ago
NPCE Explains How NeuroPace's RNS System Makes Money
NPCE Explains How NeuroPace's RNS System Makes Money
MSN · 11 days ago
NPCE - Neuropace Inc. stock news, filings & ratings
NPCE - Neuropace Inc. stock news, filings & ratings
Quantisnow · 12 days ago
NeuroPace receives FDA approval for AI-driven ECoG Assistant
NeuroPace receives FDA approval for AI-driven ECoG Assistant
Investing.com · 12 days ago
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Business Wire · 12 days ago
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Yahoo Finance · 12 days ago
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
Business Wire · 12 days ago
NeuroPace (NPCE) CMO has 358 shares withheld to cover RSU taxes
NeuroPace (NPCE) CMO has 358 shares withheld to cover RSU taxes
Stock Titan · 13 days ago